S Patel Medical Limited 12572287 false 2024-05-01 2025-04-30 2025-04-30 The principal activity of the company is general medical practice activities. Digita Accounts Production Advanced 6.30.9574.0 true 12572287 2024-05-01 2025-04-30 12572287 2025-04-30 12572287 core:RetainedEarningsAccumulatedLosses 2025-04-30 12572287 core:ShareCapital 2025-04-30 12572287 core:CurrentFinancialInstruments core:WithinOneYear 2025-04-30 12572287 bus:SmallEntities 2024-05-01 2025-04-30 12572287 bus:AuditExemptWithAccountantsReport 2024-05-01 2025-04-30 12572287 bus:FullAccounts 2024-05-01 2025-04-30 12572287 bus:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 12572287 bus:RegisteredOffice 2024-05-01 2025-04-30 12572287 bus:Director1 2024-05-01 2025-04-30 12572287 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 12572287 core:PlantMachinery 2024-05-01 2025-04-30 12572287 countries:EnglandWales 2024-05-01 2025-04-30 12572287 2023-05-01 2024-04-30 12572287 2024-04-30 12572287 core:RetainedEarningsAccumulatedLosses 2024-04-30 12572287 core:ShareCapital 2024-04-30 12572287 core:CurrentFinancialInstruments core:WithinOneYear 2024-04-30 iso4217:GBP xbrli:pure

Registration number: 12572287

S Patel Medical Limited

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Year Ended 30 April 2025

 

S Patel Medical Limited

Contents

Abridged Balance Sheet

1

Notes to the Unaudited Abridged Financial Statements

2 to 3

 

S Patel Medical Limited

(Registration number: 12572287)
Abridged Balance Sheet as at 30 April 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

2,837

-

Current assets

 

Debtors

31,500

29,500

Cash at bank and in hand

 

104,275

87,857

 

135,775

117,357

Creditors: Amounts falling due within one year

(10,044)

(9,695)

Net current assets

 

125,731

107,662

Total assets less current liabilities

 

128,568

107,662

Provisions for liabilities

(539)

-

Net assets

 

128,029

107,662

Capital and reserves

 

Called up share capital

100

100

Profit and loss account

127,929

107,562

Total equity

 

128,029

107,662

For the financial year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the director on 30 October 2025
 

Dr S Patel

Director

 

S Patel Medical Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Calyx House
South Road
Taunton
Somerset
TA1 3DU

These financial statements were authorised for issue by the director on 30 October 2025.

2

Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover represents the amounts, excluding value added tax, derived from the provision of goods and services to customers during the year.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

S Patel Medical Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

25% straight line

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 1).

4

Tangible assets

Total
£

Cost or valuation

Additions

3,783

At 30 April 2025

3,783

Depreciation

Charge for the year

946

At 30 April 2025

946

Carrying amount

At 30 April 2025

2,837